| Rachael Marie Knuteson, NP | |
|
1948 S Eagle Rd, Meridian, ID 83642-2452 | |
| (208) 322-7900 | |
| Not Available |
| Full Name | Rachael Marie Knuteson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1948 S Eagle Rd, Meridian, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003409988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 67084 (Idaho) | Primary |
| Entity Name | Gary Gregerson Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255762506 PECOS PAC ID: 3173838141 Enrollment ID: O20150819009414 |
News Archive
A new inhibitor helps previously nicotine-addicted rats stay on the wagon, according to a study published on October 22nd in The Journal of Experimental Medicine.
Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis (1). Its potential for treating the disease was discovered in 2006 thanks to the work of Frédéric Becq's team at the Institute of Cell Physiology and Biology (CNRS/Université de Poitiers), funded by the associations Vaincre la Mucoviscidose, MucoVie66, La Pierre Le Bigaut and ABCF2.
A study published today in the journal Nature Genetics explores a new mechanism that may contribute to the development of several tumours, including Chronic Lymphocytic Leukaemia, a type of cancer that affects more than a thousand new patients in Spain each year.
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachael Marie Knuteson, NP 6472 E Dannsmore Dr, Nampa, ID 83687-4116 Ph: (208) 296-0242 | Rachael Marie Knuteson, NP 1948 S Eagle Rd, Meridian, ID 83642-2452 Ph: (208) 322-7900 |
News Archive
A new inhibitor helps previously nicotine-addicted rats stay on the wagon, according to a study published on October 22nd in The Journal of Experimental Medicine.
Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis (1). Its potential for treating the disease was discovered in 2006 thanks to the work of Frédéric Becq's team at the Institute of Cell Physiology and Biology (CNRS/Université de Poitiers), funded by the associations Vaincre la Mucoviscidose, MucoVie66, La Pierre Le Bigaut and ABCF2.
A study published today in the journal Nature Genetics explores a new mechanism that may contribute to the development of several tumours, including Chronic Lymphocytic Leukaemia, a type of cancer that affects more than a thousand new patients in Spain each year.
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
› Verified 7 days ago
Jennifer Lytle, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3280 E Lanark Dr, Meridian, ID 83642 Phone: 208-895-8670 Fax: 208-955-0494 | |
Josef Mcguire, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3080 E Gentry Way Ste 210, Meridian, ID 83642 Phone: 208-384-9022 | |
Melanie Maltese, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14 S Baltic Pl, Meridian, ID 83642 Phone: 208-887-4872 | |
Michael Pahang, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1550 N Crestmont Dr, Meridian, ID 83642 Phone: 208-288-4200 Fax: 208-288-4279 | |
Gloria M Beery, AS, BSN, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1545 E Leighfield Dr, Suite 100, Meridian, ID 83646 Phone: 208-855-2710 Fax: 208-855-0883 | |
Vanessa R Holstine, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3525 E Louise Dr Ste 500, Meridian, ID 83642 Phone: 208-706-7050 |